Compare VSH & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSH | VCEL |
|---|---|---|
| Founded | 1962 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | N/A | 1997 |
| Metric | VSH | VCEL |
|---|---|---|
| Price | $18.29 | $37.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $57.50 |
| AVG Volume (30 Days) | ★ 1.4M | 586.8K |
| Earning Date | 02-04-2026 | 02-26-2026 |
| Dividend Yield | ★ 2.19% | N/A |
| EPS Growth | N/A | ★ 236.54 |
| EPS | N/A | ★ 0.25 |
| Revenue | ★ $2,982,842,000.00 | $258,716,999.00 |
| Revenue This Year | $5.15 | $17.86 |
| Revenue Next Year | $6.09 | $18.55 |
| P/E Ratio | ★ N/A | $151.65 |
| Revenue Growth | N/A | ★ 14.05 |
| 52 Week Low | $10.35 | $29.24 |
| 52 Week High | $19.81 | $63.00 |
| Indicator | VSH | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 76.59 | 48.73 |
| Support Level | $15.95 | $35.99 |
| Resistance Level | $16.56 | $41.65 |
| Average True Range (ATR) | 0.57 | 1.75 |
| MACD | 0.27 | -0.01 |
| Stochastic Oscillator | 97.34 | 32.12 |
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.